Early Access — free while we kick the tires
EdgarHawk

Gwillim Ryan M

E.V.P. , CFO, CSO

Officer
2 filings analyzed · 1 company · Latest 2026-02-18

Companies

Company Buys Sells Direction
BRUNSWICK CORP BC 0 7 Net selling

Activity

February 2026
2026-02-18 BRUNSWICK CORP BC
high
Sell
12,785 shares
$1,115,236
Significance 6/10

CFO Gwillim Ryan M sold 12.8K BC shares at $87.23 on 2026-02-17 (total $1.1M); 90-day timing pattern 100% well-timed at this ticker.

Gwillim Ryan M, E.V.P., CFO, and CSO, sold 12,785 shares of Brunswick Corporation at $87.23, reducing his holdings by 28.4% from 45,040 to 32,255 shares. His prior two open-market sales at this ticker both showed negative 90-day returns (-13.4% and -6.6%), indicating consistent well-timed exit patterns. The current company backdrop is material: Brunswick posted net income of $-235,500,000 over its most recent full fiscal year, making it unprofitable, while annual revenue growth stood at only +2.4%. The stock now trades at $89.22, near its 52-week high of $89.22, having appreciated 50.4% over the past 90 days since this insider's sale execution. This combination of a profitable insider—whose prior sales at this exact ticker preceded downturns—selling a meaningful portion during strong price momentum in an unprofitable company warrants investor attention to the underlying operational trajectory.

February 2025
2025-02-18 BRUNSWICK CORP BC
medium
Sell
8,253 shares
$537,188
Significance 5/10

EVP/CFO M. Gwillim Ryan sold 8,253 shares of BRUNSWICK CORP at $65.09 on 2025-02-18; stock down 32.9% from 52-week high of $96.52.

Gwillim Ryan, serving as E.V.P., CFO, and CSO, sold 8,253 shares worth $537,187.77 at $65.09, reducing his holdings by -18.2% from 45.4K to 37.1K shares. This sale occurred as BRUNSWICK CORP trades 32.9% below its 52-week high of $96.52 and has declined 17.4% over the past 90 days. His cross-ticker track record shows a 100.00% well-timed rate on prior sells, with the one prior sale at this ticker on 2024-02-16 achieving a -6.6% return over 90 days, indicating the stock fell after his sale. However, current valuation metrics show a P/E of 33.40 paired with annual revenue decline of -18.2%, suggesting operational headwinds that may explain the broader stock weakness. The timing of this sale relative to the stock's deterioration and the company's revenue contraction warrants attention to whether this reflects awareness of near-term business challenges.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access